Studi clinici su Obesità nello stato di Arizona
40 studi su Obesità cercano partecipanti presso sedi nello stato di Arizona.
Città nello stato di Arizona
Testo ufficiale dello studio (inglese)
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- Headlands Research - Scottsdale /ID# 282571, Scottsdale
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT07752979A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Pima Heart, Tucson
- Eclipse Clinical Research, Tucson
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07783802Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
- AMR Clinical, Tempe
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07837973Early Tracking of Childhood Health Determinants (ETCHED) Study
- NIDDK, Phoenix, Phoenix
In reclutamentoStudio osservazionaleVolontari sani benvenuti
1 Day – 99 Years · Tutti i sessi · Aggiornato il 28 set 2026 · NCT03481829A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- University of Arizona, Tucson
In reclutamentoFase 3
Età da 6 a 17 · Tutti i sessi · Aggiornato il 24 set 2026 · NCT06672549A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Tucson Clinical Research Institute, Tucson
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- RIO Clinical Trials - Phoenix, Phoenix
- Headlands Research - Scottsdale, Scottsdale
- Novak Clinical Research - Tucson - North La Cholla Boulevard, Tucson
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07392190A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Mesa
- Research Site, Phoenix
- Research Site, Tucson
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07784270Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Synexus Clinical Research US, Inc., Phoenix
- Medical Advancement Centers of Arizona, Phoenix
In reclutamentoFase 3
Età da 45 a 99 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07037433A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Headlands Research - Scottsdale, Scottsdale
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07321886Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Care Access - 801 South Power Road, Mesa, Mesa
- Elite Pain and Spine Institute - South Crimson Road, Mesa
- Elite Clinical Studies, LLC, Phoenix
- e altri 1
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07353931A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- The Institute for Liver Health II dba Arizona Clinical Trials - Mesa, Chandler
- Headlands Research - Scottsdale, Scottsdale
- The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07589608Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
- NIDDK, Phoenix, Phoenix
In reclutamentoVolontari sani benvenuti
Età da 18 a 99 · Tutti i sessi · Aggiornato il 21 set 2026 · NCT06223555A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Phoenix
- AURORA-1 Clinical Site, Tucson
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 16 set 2026 · NCT07743463A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Peoria
- AURORA-2 Clinical Site, Phoenix
- AURORA-2 Clinical Site, Tucson
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 16 set 2026 · NCT07743450Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- HonorHealth, Phoenix
- Medical Advancement Centers of Arizona, Phoenix
- Pima Heart and Vascular Clinical Research, Tucson
- e altri 1
In reclutamentoFase 3
Età da 18 a 99 · Tutti i sessi · Aggiornato il 16 set 2026 · NCT07037459A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Arizona Clinical Trials, Tucson
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 14 set 2026 · NCT07351058A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Helios Clinical Research - Phoenix, Phoenix
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 14 set 2026 · NCT06897475A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Arizona Clinical Trials, Tucson
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 14 set 2026 · NCT07351045A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Chandler
- ACCOMPLISH-2 Research Site, Phoenix
- ACCOMPLISH-2 Research Site, Sun City West
- e altri 1
In reclutamentoFase 3Volontari sani benvenuti
Età da 18 a 79 · Tutti i sessi · Aggiornato il 11 set 2026 · NCT07654374AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Dignity Health, Mercy Gilbert, Gilbert
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 9 set 2026 · NCT07571109A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- The Institute for Liver Health II dba Arizona Clinical Trials - Mesa, Chandler
- Headlands Research - Scottsdale, Scottsdale
- The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 8 set 2026 · NCT06143956A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
- Prime Medical Group, LLC dba Gilbert Center for Family Medicine, LLC, Gilbert
- Synexus Clinical Research US, Inc., Phoenix
- Pima Heart, Tucson
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 8 set 2026 · NCT07215559A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Medical Dermatology Specialists, Phoenix
In reclutamentoFase 4
Età 18 e oltre · Tutti i sessi · Aggiornato il 4 set 2026 · NCT06857942Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Phoenix
- Kailera Clinical Site, Sun City
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 3 set 2026 · NCT07284901Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
- Kailera Clinical Site, Sun City
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 3 set 2026 · NCT07284875Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Gilbert Center for Family Medicine, Gilbert
In reclutamentoFase 3
Età da 18 a 99 · Tutti i sessi · Aggiornato il 3 set 2026 · NCT07684144Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
- Kailera Clinical Site, Glendale
- Kailera Clinical Site, Phoenix
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 set 2026 · NCT07284979The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure
- NIDDK, Phoenix, Phoenix
In reclutamentoVolontari sani benvenuti
Età da 18 a 60 · Tutti i sessi · Aggiornato il 28 ago 2026 · NCT05545306Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
- Arizona Clinical Trials, Chandler
- Epic Medical Research - Sun City, Sun City
In reclutamentoFase 3
Età da 18 a 99 · Tutti i sessi · Aggiornato il 27 ago 2026 · NCT07575399A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Mesa
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 ago 2026 · NCT07784725Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity
- Exponent Phoenix, Phoenix
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 20 ago 2026 · NCT07776678A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Mercy Gilbert Medical Center, Gilbert
- Sun City Clinical Research, Glendale
- Honor Health, Phoenix
- e altri 1
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 18 ago 2026 · NCT07567001Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Phoenix
- ACCOMPLISH-1 Research Site, Sun City West
- ACCOMPLISH-1 Research Site, Tucson
In reclutamentoFase 3
Età da 18 a 79 · Tutti i sessi · Aggiornato il 10 ago 2026 · NCT07654361Fibrosis Lessens After Metabolic Surgery
- Banner Health Center, Phoenix
In reclutamentoFase 4Volontari sani benvenuti
Età da 18 a 75 · Tutti i sessi · Aggiornato il 31 lug 2026 · NCT06374875A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
- Arizona Research Center, Inc., Phoenix
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 9 lug 2026 · NCT07481630A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)
- Arizona Liver Health, Chandler
- Adobe Clinical Research, Tucson
In reclutamentoFase 1/2
Età da 18 a 65 · Tutti i sessi · Aggiornato il 8 lug 2026 · NCT06836609Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity
- Mayo Clinic in Arizona, Scottsdale
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 30 a 70 · Tutti i sessi · Aggiornato il 28 gen 2026 · NCT04232566Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
- The University of Arizona College of Medicine- Phoenix, Phoenix
In reclutamentoFase 3
Età da 18 a 75 · Tutti i sessi · Aggiornato il 14 nov 2025 · NCT06499857A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans
- PRANDIAL Lab, Flagstaff
In reclutamentoVolontari sani benvenuti
Età 18 e oltre · Tutti i sessi · Aggiornato il 14 nov 2024 · NCT04755062Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.